Type of Study:
Contraception
Study Length:
24 months
Target Age/Sex:
35 years or younger female subjects
Benefits:
Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.
Link: ClinicalTrials.gov
Staus: Closed
Description:
A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant (Nexplanon) Beyond 3 Years of Use.
To learn more, fill out the form or call 208-557-2991 or 208-557-2924.